Podcast
MSL Talk: Tom Caravela, Sarah Snyder
MSL Training: The Path of Continued Learning and Development
Summary
In this episode, Michael Parisi and Marissa Polly from GuideMark Health join to explore the evolving training needs of Medical Science Liaisons (MSLs). They discuss the essential scientific and clinical skills required, alongside strategies for reengaging field medical teams post-COVID. The conversation highlights the importance of soft skills and empathy in MSL success, and offers insights into enhancing operational training and territory management. Michael and Marissa also address the challenges new MSLs face during career transitions, inviting listener input. The episode concludes with closing remarks and a note of appreciation, with GuideMark Health as the sponsor.
Check out my latest podcast with Michael Parisi and Marissa Poli of Guidemark Health as we cover MSL Training: The Path of Continued Learning and Development.
We discuss:
Core Competency-Scientific and Clinical Training
Soft Skills and Empathy Training
Operational Skills in a Virtual World
Career On Ramp Training
MSL training, medical science liaison skills, soft skills in healthcare, operational training for MSLs, career transition for MSLs
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Sarah Snyder
Podcast
MSL Talk: Tom Caravela, John Caskey
Prepare to LAUNCH: How to Build an MSL Team From Scratch
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO